Aptevo Therapeutics Inc. (APVO) DCF Valuation

Aptevo Therapeutics Inc. (APVO) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Aptevo Therapeutics Inc. (APVO) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment strategies with the Aptevo Therapeutics Inc. (APVO) DCF Calculator! Explore real financial data, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of Aptevo Therapeutics Inc. (APVO).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 32.4 4.3 12.3 3.1 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -86.71 185.26 -74.67 -100 -40.34 -40.34 -40.34 -40.34 -40.34
EBITDA -39.5 -26.1 -20.3 -27.7 -28.3 .0 .0 .0 .0 .0
EBITDA, % -121.91 -605.43 -164.79 -890.82 100 -60 -60 -60 -60 -60
Depreciation 2.2 1.4 1.1 .9 .6 .0 .0 .0 .0 .0
Depreciation, % 6.89 32.63 9.31 28.93 100 35.55 35.55 35.55 35.55 35.55
EBIT -41.8 -27.5 -21.4 -28.6 -28.9 .0 .0 .0 .0 .0
EBIT, % -128.8 -638.06 -174.1 -919.75 100 -60 -60 -60 -60 -60
Total Cash 12.4 40.0 45.0 22.6 16.9 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 2.4 3.7 2.5 .0
Account Receivables, % 0 54.98 29.81 80.28 100
Inventories 6.1 4.8 3.1 1.6 .0 .0 .0 .0 .0 .0
Inventories, % 18.93 111 25.07 50.45 100 58.89 58.89 58.89 58.89 58.89
Accounts Payable 6.4 5.6 3.5 3.5 4.0 .0 .0 .0 .0 .0
Accounts Payable, % 19.82 129.57 28.16 112.36 100 69.6 69.6 69.6 69.6 69.6
Capital Expenditure -.2 -.1 -.7 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -0.47187 -2.04 -5.8 -0.93128 100 -1.85 -1.85 -1.85 -1.85 -1.85
Tax Rate, % 6.64 6.64 6.64 6.64 6.64 6.64 6.64 6.64 6.64 6.64
EBITAT -39.2 -16.4 -19.9 -174.2 -27.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -36.9 -16.9 -21.2 -170.7 -21.8 -4.0 .0 .0 .0 .0
WACC, % 8.98 7.76 8.94 9.2 8.96 8.77 8.77 8.77 8.77 8.77
PV UFCF
SUM PV UFCF -3.7
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -4
Net Debt -12
Equity Value 8
Diluted Shares Outstanding, MM 0
Equity Value Per Share 28.21

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real APVO financials.
  • Real-World Data: Access to historical data and forward-looking estimates (highlighted in the yellow cells).
  • Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Quickly see how your inputs affect Aptevo’s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Customizable Financial Metrics: Adjust essential inputs such as revenue projections, R&D spending, and operational costs.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other financial metrics with ease.
  • High-Precision Accuracy: Utilizes Aptevo's actual financial data for dependable valuation results.
  • Effortless Scenario Testing: Explore various assumptions and analyze results without hassle.
  • Efficiency Booster: Remove the necessity of constructing intricate valuation models from the ground up.

How It Works

  • 1. Download the Template: Obtain and open the Excel file featuring Aptevo Therapeutics Inc.'s (APVO) preloaded data.
  • 2. Adjust Assumptions: Modify essential inputs such as growth projections, WACC, and capital expenditures.
  • 3. Analyze Results Immediately: The DCF model automatically computes intrinsic value and NPV.
  • 4. Explore Scenarios: Evaluate various forecasts to assess different valuation possibilities.
  • 5. Present with Assurance: Deliver expert valuation insights to enhance your decision-making process.

Why Choose This Calculator for Aptevo Therapeutics Inc. (APVO)?

  • Accurate Data: Utilize real Aptevo financials for trustworthy valuation outcomes.
  • Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Built-in calculations save you the hassle of starting from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants focusing on biotechnology.
  • User-Friendly: An intuitive design and clear instructions ensure accessibility for all users.

Who Should Use Aptevo Therapeutics Inc. (APVO)?

  • Investors: Make informed investment choices with insights into innovative therapeutic solutions.
  • Healthcare Analysts: Streamline your analysis with comprehensive data on drug development and market potential.
  • Consultants: Easily customize reports for clients interested in biotechnology advancements.
  • Biotech Enthusiasts: Expand your knowledge of therapeutic innovations and their impact on patient care.
  • Educators and Students: Utilize it as a valuable resource in biotechnology and pharmaceutical studies.

What the Template Contains

  • Pre-Filled DCF Model: Aptevo Therapeutics Inc.'s (APVO) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Aptevo's profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.